Paradigm Biopharmaceuticals Ltd.ASX: PAR

Application for quotation of securities - PAR

Aug 25, 2026 at 4:03 AM EDT · Issued by Paradigm Biopharmaceuticals Ltd. via ASX

Filed with ASX · Aug 25, 2026 at 4:03 AM EDT

On 6ix: 6ix.com/news/application-for-quotation-of-securities-par-3

Appendix 2A - Application for quotation of securities Appendix 2A - Application for quotation of securities 1 / 6 Announcement Summary Entity name PARADIGM BIOPHARMACEUTICALS LIMITED.. Announcement Type New announcement Date of this announcement Tuesday August 25, 2026 The +securities to...

View Attachment

6ix hasn’t read this filing yet.

Paradigm Biopharmaceuticals Ltd. on 6ix

Earlier from Paradigm Biopharmaceuticals

80% Safety Review Complete, September IA on TrackAug 12
June 2026 Quarterly Activities Report & Appendix 4CJul 29
Paradigm Receives $5.75m R&D Tax Incentive RefundJul 21
Drawdown of Tranche 4 under the Convertible Note FacilityJul 12
PAR Completes Enrolment in Pivotal Phase 3Jun 14

Later from Paradigm Biopharmaceuticals

Appendix 4G and Corporate Governance StatementAug 27
Appendix 4E and 2026 Annual ReportAug 27
Melbourne Investor LunchSep 2
Notification regarding unquoted securities - PARSep 10
Notice under Section 708ASep 10

All Paradigm Biopharmaceuticals news releases

Follow Paradigm Biopharmaceuticals into a list and get an email when it puts out news.

Follow Paradigm Biopharmaceuticals